Drugs Made In America Acquisition (DMAAR) Current Assets (2024 - 2025)
Drugs Made In America Acquisition (DMAAR) posted Current Assets of $12191.0 for Q4 2025, down 56.76% on a QoQ basis from $28196.0 in Q3 2025, and up 144.26% year-over-year from $4991.0 in Q4 2024.
Drugs Made In America Acquisition (DMAAR) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition's Current Assets history runs 2 years deep, the most recent figure standing at $12191.0 for Q4 2025.
- Quarterly Current Assets rose 144.26% year-over-year to $12191.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12191.0 (up 144.26% YoY) and the FY2025 annual result came in at $12191.0, up 144.26% from the prior year.
- Current Assets was $12191.0 for Q4 2025 at Drugs Made In America Acquisition, down from $28196.0 in the prior quarter.
- Across five years, Current Assets topped out at $71019.0 in Q1 2025 and bottomed at $4991.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 607,146.00 |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | 436,863.00 |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 663,358.00 |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 296,250.00 |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | 1,946.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | 193,640.00 |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 462,819.00 |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 1.47 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 1.67 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 12,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,191.00 |
| Sep 30, 2025 | 28,196.00 |
| Jun 30, 2025 | 49,726.00 |
| Mar 31, 2025 | 71,019.00 |
| Dec 31, 2024 | 4,991.00 |